Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

Market Cap	1.12B +1.1%
Revenue (ttm)	1.02B +1.9%
Net Income	45.75M -14.8%
EPS	0.07 -15.5%
Shares Out	n/a
PE Ratio	24.38
Forward PE	15.44
Dividend	0.03 (4.05%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	40
Open	0.7350
Previous Close	0.7350
Day's Range	0.7350 - 0.7350
52-Week Range	0.5650 - 0.9700
Beta	n/a
RSI	54.13
Earnings Date	Mar 30, 2026

About FRA:XIN

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 7,296
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XIN

Financial Performance

In 2024, FRA:XIN's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY